Immunotherapy targeting the CLTA4 protein in HCV-related HCC demonstrated modest extended survival in a disease that has a high mortality rate.
Despite HCC having a poor prognosis and high mortality, systemic antiangiogenesis therapies offer some hope to patients.
This patient information fact sheet explains the causes, symptoms, and treatments associated with esophageal cancer.
This patient information fact sheet provides information on the definition and causes of stomach cancer, along with available treatments.
A bacterium implicated in periodontal disease may also contribute to colorectal cancer.
An expert reviews the new maintenance, second- and third-line therapies for colorectal cancer treatment presented at the 2013 Gastrointestinal Cancers Symposium.
An imaging system no bigger than a multivitamin capsule produces high-resolution images without the need for sedation or training in endoscopy.
C. Andrew Kistler, MD, PharmD, RPh, discusses how severe GI symptoms caused by ipilimumab can best be managed.
The E-cadherin (CDH1) gene plays an intricate role in the development of diffuse gastric cancer.
Author: C. Andrew Kistler, MD, PharmD, RPh
Colorectal cancer is the 3rd most common cancer, and the 2nd most common cause of death in the United States. ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|